Skip to main content

Global Epilepsy Market Gross Margin Driving Essential Factors and Trends Influencing Growth of Industry

Global Epilepsy Market Research Overview by Condition (Epilepsy Drug Resistant/Intractable Epilepsy, Others), by Diagnosis & Treatment (Diagnosis & Treatment), by End-use (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others), and Regional Analysis, Industry Size, Growth, Technology and Trend – Forecast till 2023
Epilepsy Market Size is Expected to touch a Global worth of USD 9,509.2 million by 2023, exhibiting a CAGR of 8.20% over the forecast period (2018-2023).
Epilepsy has been known as the fourth most prevalent neurological ailment. It is s chronic condition that triggers recurrent and unprovoked seizures. It can affect anyone irrespective of their ages.
World Health Organization records that in 2017, almost 50 million individuals throughout the world suffer from epilepsy, making it one of the most prevalent neurological disorders worldwide. Almost 80% of the people affected by epilepsy have been estimated to live in low- and middle-income economies.
Major Industry Competitive Analysis
Top Epilepsy Industry Key players in the Global Regional Landscapes given as Follows –
  • Eisai Co. Ltd.
  • Novartis AG
  • Pfizer Inc.
  • GW Pharmaceuticals PLC
  • Abbott Laboratories
  • UCB SA
  • LivaNova PLC
  • Medtronic PLC
  • Johnson & Johnson Services Inc.
  • GlaxoSmithKline PLC
  • NeuroPace Inc.
  • and Others.
Epilepsy Market Segmentation
The global epilepsy market is segmented by condition, diagnosis & treatment, and end-user.
By condition, the epilepsy market is divided into epilepsy drug resistant/intractable epilepsy and others.
By diagnosis and treatment, the epilepsy market is segmented into diagnosis– imaging devices, blood tests, and others
and treatment- anti-epileptic drugs, neurostimulation devices, brain surgery, ketogenic diet, and others.
By end-user, the epilepsy market include hospitals, clinics, ambulatory surgical centers, diagnostic centers, and others.
Geographically the Epilepsy Market Has been Segmented into Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). Among all the Americas leads the worldwide market for anti-epilepsy drugs on account of the growing incidents of epilepsy, availability of the advanced technologies, along with the enhanced healthcare infrastructure within the region. Europe holds the second share in the market owing to increasing healthcare outlays, surging healthcare R&D spending by the governing bodies, and rapid patient population.
Browse Complete Premium Report Details at: https://www.marketresearchfuture.com/reports/epilepsy-market-7730
The Asia Pacific region has been the fastest expanding market due to the presence of developing countries like China and India. These regions have large patient population and the countries are putting additional efforts in growing their healthcare outlays. And Middle East and Africa holds the least market share particularly because of the presence of strict government regulations and the poor economic conditions prevailing within the African market.
LIST OF TABLES
TABLE 1 MARKET SYNOPSIS
TABLE 2 PRIMARY INTERVIEWS
TABLE 3 GLOBAL EPILEPSY MARKET, BY CONDITION, 2015–2023 (USD MILLION)
TABLE 4 GLOBAL EPILEPSY MARKET, FOR EPILEPSY DRUG-RESISTANT/ INTRACTABLE EPILEPSY, BY REGION 2015–2023 (USD MILLION)
TABLE 5 GLOBAL EPILEPSY MARKET, FOR OTHERS, BY REGION 2015–2023 (USD MILLION)
TABLE 6 GLOBAL EPILEPSY MARKET, BY DIAGNOSIS & TREATMENT, 2015–2023 (USD MILLION)
TABLE 7 GLOBAL EPILEPSY MARKET, FOR DIAGNOSIS, BY REGION, 2015-2023 (USD MILLION)
TABLE 8 GLOBAL EPILEPSY MARKET, FOR TREATMENT, BY REGION, 2015-2023 (USD MILLION)
TABLE 9 GLOBAL EPILEPSY MARKET, FOR DIAGNOSIS, BY TYPE 2015–2023 (USD MILLION)
TABLE 10 GLOBAL EPILEPSY MARKET, FOR IMAGING DEVICES, BY TYPE 2015–2023 (USD MILLION)
TABLE 11 GLOBAL EPILEPSY MARKET, FOR TREATMENT, BY TYPE 2015–2023 (USD MILLION)
TABLE 12 GLOBAL EPILEPSY MARKET, FOR ANTI-EPILEPTIC DRUGS, BY TYPE 2015–2023 (USD MILLION)
Continued…
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more